Wednesday, October 6, 2010

T cell discovery shows promise for Type 1 diabetes treatment

A research team from the University of British Columbia and the Child and Family Research Institute (CFRI) at BC Children’s Hospital has identified the role of a type of T cell in type 1 diabetes that may lead to new treatment options for young patients.

Also known as juvenile diabetes, type 1 diabetes is an autoimmune disease primarily affecting children and young adults. In patients with type 1 diabetes, the body attacks itself by destroying insulin-producing cells in the pancreas that regulate glucose, or blood sugar.
Led by Rusung Tan, a Pathology professor in the UBC Faculty of Medicine and co-head of the Immunity in Health and Disease research cluster at CFRI, the research team has identified the increased presence of Th17 cells, a type of T cell discovered in 2005, in children newly diagnosed with type 1 diabetes.

"T cells are white blood cells and key members of the immune system that control infections," says Tan, who is also a member of the Department of Pathology & Laboratory Medicine at BC Children’s Hospital and a senior scholar of the Michael Smith Foundation for Health Research.

"In healthy individuals, Th17 cells provide a strong defence against bacteria and viruses by guiding the immune system to strongly attack infected targets within our bodies."

However, Th17 has been associated with other autoimmune diseases such as Crohn’s disease, which suggests they can play a harmful role. Treatments designed to block Th17 cells are in clinical trials for these diseases.

“The elevated levels of Th17 cells in type 1 diabetes patients suggest that these cells may also play a key role in the early development of this disease in young patients,” says Tan. “This discovery opens the door to new treatments for childhood diabetes that target Th17 cells.”
The findings are published in the current issue of the Journal of Immunology. The team consists of researchers from UBC, CFRI and the Vancouver Coastal Health Research Institute. At the time of the study, lead author Dr. Ashish Marwaha was a master’s student at UBC and CFRI. The study was supported by grants from the Canadian Institutes of Health Research and the Juvenile Diabetes Research Foundation.

Microscopic image of a pancreatic islet, where insulin-producing cells live. Figure 1 (above) shows the beginning of an infiltration by white blood cells, many of which may be Th17. Figure 2 (below) shows a later stage of the infiltration in which most of the insulin-producing cells have been destroyed.




  1. Hello,

    Thank you for this useful information for Th17 cells. These cells have been identified as a unique subset of T-helper cells and constitute a subset of cells known as neutrophil regulatory T-cells....

  2. Greetings to everyone that is reading this testimony..I want to use this medium to testify of how i got cured totally from Lupus,I was diagnose with Lupus 2 years ago, and ever since i have done a lot of Chemo and Radiation but nothing worked out for me, but only damaged my immune system and render me weak and helpless. I came across testimonies on how Dr Molemen healed Several patients living with Lupus and Herpes Virus, just with his herbal medicine which he normally prepare for them, after doing some research on this great man, i left no hope than to contact Dr Molemen with faith that God could also heal me with his servant medicine, to my greatest surprise after 2 weeks of taking Dr Molemen medicine which he sent to me, i am totally free and healed from Lupus. I'm now here to testify that am no more a Lupus patient, and now am so much happy if you need help for your HERPES CURE OR LYME DISEASE/CANCER OR HIV&AIDS contact him today for his healing medicine,email ( / or call him on +2347036013351.

    Forever Remain Bless Dr Molemen